Holen Sie sich die Stockscreener-App
19.60
1.95%
-0.39
Vorhandelsmarkt:
19.54
-0.06
-0.31%
Finanzdaten der Roivant Sciences Ltd-Aktie (ROIV)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
71.33%
2.17
|
7.57 | 9.018 | 4.475 | 55.13 |
Operating Expenses
|
1.86%
287.09
|
292.54 | 283.40 | 346.19 | 285.70 |
| Benefits Costs and Expenses |
28.87%
271.43
|
210.62 | 243.53 | 228.86 | -15.01 |
| Costs And Expenses |
28.87%
271.43
|
210.62 | 243.53 | 228.86 | -15.01 |
| Operating Income/Loss |
0.02%
-284.92
|
-284.96 | -274.38 | -341.71 | -120.19 |
| Income/Loss From Continuing Operations Before Tax |
32.61%
-269.26
|
-203.05 | -234.51 | -224.38 | 70.14 |
| Income Tax Expense/Benefit |
90.57%
4.649
|
49.32 | -25.57 | 12.46 | 12.65 |
| Income/Loss From Continuing Operations After Tax |
8.53%
-273.91
|
-252.38 | -208.94 | -236.84 | 57.49 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | 327.02 | -43.08 | 89.09 |
|
Net Income/Loss
|
8.53%
-273.91
|
-252.38 | 118.08 | -279.92 | 57.49 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
10.14%
-50.56
|
-45.90 | -51.31 | -49.74 | -37.81 |
| Basic Average Shares |
11,586%
680.29
|
-5.9226 | 722.72 | 735.47 | 735.82 |
| Diluted Average Shares |
11,586%
680.29
|
-5.9226 | 722.72 | 735.47 | 781.63 |
| Basic Earnings Per Share |
13.79%
-0.33
|
-0.29 | 0.23 | -0.31 | 0.13 |
| Diluted Earnings Per Share |
13.79%
-0.33
|
-0.29 | 0.23 | -0.31 | 0.12 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):